Blog - INTERNET MÉDICA

■ Do androgen-directed therapies improve outcomes in prostate cancer patients undergoing radical prostactomy? A systematic review and meta-analysis

Ameeta L. Nayak, Anathea S. Flaman, Ranjeeta Mallick et al

Can Urol Assoc J 2021, vol 15(8): 269–279

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418268/

■ Prostate cancer – focus on cholesterol

Lucija Škara, Ana Huđek Turković, Ivan Pezelj, et al

Cancers (Basel) 2021, vol 13(18): 469

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469848/

■ Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol

Katharina Beyer, Lisa Moris, Michael Lardas et al

The PIONEER Consortium

BMJ Open.2021, vol 11(2): e040531

https://bmjopen.bmj.com/content/11/2/e040531

■ A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy

Amy Pawson, Zonia Ghumman, Phillip H. Kuo et al

Can Urol Assoc J.2020, vol 14(4): 130–138

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7124170/

■ A review of prostate cancer treatment impact on the CNS and cognitive function

Charles Ryan, Jeffrey S. Wefel, Alicia K. Morgans

Prostate Cancer Prostatic Dis.2020, vol 23(2): 207–219.

https://www.nature.com/articles/s41391-019-0195-5

■ Diagnosing hereditary cancer predisposition in men with prostate cancer

Mary Pritzlaff, Yuan Tian, Patrick Reineke et al

Genet Med.2020, vol 22(9): 1517–152

https://www.nature.com/articles/s41436-020-0830-5

■ Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancer

Rebeca Lozano, Elena Castro, Isabel M. Aragón et al

Br J Cancer. 2021, vol 124(3): 552–563

https://www.nature.com/articles/s41416-020-01114-x

■ Shift work and prostate cancer: an updated systematic review and meta-analysis

Mario Rivera-Izquierdo, Virginia Martínez-Ruiz, Elena Mercedes Castillo-Ruiz et al

Int J Environ Res Public Health. 2020 Feb; 17(4): 1345

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068593/

■ Metastatic hormone-sensitive prostate cancer (mHSPC): Advances ad treatment strategies in the first-line setting

Kenrick Ng, Shievon Smith, Jonathan Shamash

Oncol Ther.2020, vol 8(2): 209–230

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020773/

■ Zinc deficiency in men over 50 and its implications in prostate disorder

Ann Katrin Sauer, Hector Vela, Guillermo Vela, Peter Stark, Eduardo Barrera-Juarez, Andreas M. Grabrucker

Front Oncol.2020, vol 0: 1293

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424038/

■ PARP inibitors in prostate and urothelial cancers

Rohan Garje, Raju Kumar Vaddepally, Yousef Zakharia

Front Oncol.2020, vol 10: 114

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020773/

■ Current and future management of locally advanced and metastatic prostate cancer

Neal D. Shore

Rev Urol.2020 vol 22(3): 110–123.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672503/

■ Can epigentic and inflammatory biomarkers identify clinically aggressive prostate cancer?

Pedro Bargão Santos, Hitendra Patel, Rui Henrique, Ana Félix

World J Clin Oncol.2020, vol 11(2): 43–52

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046922/

■ Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancerNavid Sobhani, Marianna Sirico, Daniele Generali, Fabrizio Zanconati, Bruna Scaggiante

World J Clin Oncol.2020, vol 11(7): 450–46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407926/

■ What chance do we have to decrease prostate cancer overdiagnosis and overtreatment? A narrative review

Francesco Ziglioli, Giorgia Granelli, Domenico Maria Cavalieri, Tommaso Bocchialini, Umberto Maestroni

Acta Biomed. 2019; vol 90(4): 423–426

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233784/

■ Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis

E J Bass, A Pantovic, M J Connor et al

Prostate Cancer and Prostatic Diseases 2021

https://www.nature.com/articles/s41391-021-00449-7

■ Clinical considerations for the management of androgen indifferent prostate cancer

J E Berchuck, P V Viscuse, H Beltran, A Aparicio

Prostate Cancer Prostatic Dis 2021, vol 24 (3): 623-637

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353003/

■ Associations of fat and muscle with overall survival in men with prostate cancer: a systemic review with meta-analysis

P Lopez, R U Newton, D R Taafee et al

Prostate Cancer and Prostatic Diseases 2021

https://www.nature.com/articles/s41391-021-00442-0

■ PROMISE: a real-world clinical-genomic database ,to address knowledge gaps in prostate cancer

V S Koshkin, V G Patel, R Mckay

Prostate Cancer and Prostatic Diseases 2021

https://www.nature.com/articles/s41391-021-00433-1

■ Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?

L Umlauff, M Weber, N Freitag et al

Prostate Cancer and Prostatic Diseases 2021

https://www.nature.com/articles/s41391-021-00411-7

■ Overall survival and adverse events after treatment with darolutamide vs. apalutamid vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

M Wenzel, L Nocera, C C Ruvolo et al

Prostate Cancer and Prostatic Diseases 2021

https://www.nature.com/articles/s41391-021-00395-4

■ 18F-fluciclovine P/CT performance in biochemical recurrence of prostate cancer: a systematic review

S Rais-Bahrami, J A Efstathiou, C M Turnbull et al

Prostate Cancer and Prostatic Diseases 2021

https://www.nature.com/articles/s41391-021-00382-9

■ How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer

J Sultz, L Fong

Prostate Cancer and Prostatic Diseases 2021, vol 24: 697-717

https://www.nature.com/articles/s41391-021-00340-5

■ Treating the patient and not just the cancer: therapeutic burden in prostate cancer

D E Spratt, N Shore, O Sartor et al

Prostate Cancer and Prostatic Diseases 2021, vol 24: 647-661

https://www.nature.com/articles/s41391-021-00328-1

■ Impact of family history on oncological outcomes in primary therapy for localized prostate cancer patients: a systematic review and meta-analysis

F Urabe, S Kimura, S Yamamoto et al

Prostate Cancer and Prostatic Diseases 2021, vol 24: 638-646

https://www.nature.com/articles/s41391-021-00329-0

■ Treatment of non metastatic castration-resistant prostate cancer: focus on second-generation androgen receptor inhibitors

F Saad, M Bögemann, K Suzuki, N Shore

Prostate Cancer and Prostatic Diseases 2021, vol 24: 323-334

https://www.nature.com/articles/s41391-020-00310-3

■ Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis

S Singh, C M Moore, S Punwani et al

Prostate Cancer and Prostatic Diseases 2021, vol 24: 612-622

https://www.nature.com/articles/s41391-021-00323-6

■ Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer

A Hussain, A Tripathi, C Peiczonka et al

Prostate Cancer and Prostatic Diseases 2021, vol 24: 290-300

https://www.nature.com/articles/s41391-020-00296-y

■ The role of magnetic resonance imaging in active surveillance of prostate cancer

O A Alagbe, A C Westphalen, V F Muglia

Radiologia Brasileira 2021, vol 54 (4): 246-253

https://www.scielo.br/j/rb/a/MjNT69nsVxQN4w3cy39Gnhh/?lang=en

■ Androgen deprivation in prostate cancer: benefits of home based resistance training

T Lam, B Cheema, A Hayden et al

Sports Medicine – Open 2020, vol 6: 59

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736381/

■ Repeat radiation for local recurrence of head and neck tumors and in prostate cancer

Arne Grün, Thomas Kuhnt, Thorsten Schlomm et al

Dtsch Arztebl Int.2020, vol 117(10): 167–174

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171476/

■ Castration-resistant prostate cancer: current status of therapy with Radium-223 associated with anti-androgens (enzalutamide and abiraterone) – a systematic review

D A Added Filho, M S Benedetto Filho,

Revista de Medicina 2016, vol 95 (2)

https://www.revistas.usp.br/revistadc/article/view/116011/119961

■ Câncer de próstata: Artigos de Revisão I (Prostate Cancer: Reviews I)

Arquivo Blog Internet Médica – outubro 2019

https://internetmedica.com.br/cancer-de-prostata-artigos-de-revisao-online-prostate-cancer-reviews/

out 2019

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: outubro 2021

Hipertensão Pulmonar: Artigos de Revisão II (Pulmonary Arterial Hypertension: Reviews II)

Por Paulo Leite 25/10/2021

■ Pulmonary arterial hypertension: diagnosis, treatment, and novel advances

Bradley A. Maron, Steven H. Abman, C. Greg Elliott et al

Am J Respir Crit Care Med.2021, vol 203(12): 1472–1487

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483220/

■ Prognostic power of conventional echocardiography in individuals without history of cardiovascular diseases: a systematic review and meta-analysis

L P Fernandes, A T F Barreto, Mansueto G Neto et al

Clinics 2021, vol 76

https://www.scielo.br/j/clin/a/vtDSxbrrRyFJDwnqrYKLfRd/?lang=en

■ Lung function and stress echocardiography in pulmonary arterial hypertension: a cross sectional study

G C de Almeida, M C Pereira, M M Moreira et al

São Paulo Med J 2021, vol 139 (5)

https://www.scielo.br/j/spmj/a/kMb4GQgMPVQKQvZMbJkq5YD/?lang=en

■ Echocardiography in pulmonary arterial hypertension: Comprehensive evaluation and technical considerations

Weronika Topyła-Putowska, Michał Tomaszewski, Andrzej Wysokiński, Andrzej Tomaszewski

J Clin Med.2021, vol 10(15): 3229

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348437/

■ The role of exercise doppler echocardiography to unmask pulmonary arterial hypertension in selected patients with systemic sclerosis and equivocal baseline echocardiographic values for pulmonary hypertension

Loukianos S. Rallidis, Konstantina Papangelopoulou, Anastasia Anthi et al

Diagnostics (Basel) 2021, vol 11(7): 1200.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307336/

■ Echocardiography for the assessment of pulmonary hypertension and congenital heart disease in the young

Katharina Meinel, Martin Koestenberger, Hannes Sallmon, Georg Hansmann, Guido E. Pieles

Diagnostics (Basel) 2021, vol 11(1): 4

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823322/

■ Evaluation and management of pulmonary arterial hypertension in congenital heart disease

Hassaan B. Arshad, Valeria E. Duarte

Methodist Debakey Cardiovasc J.2021; vol 17(2): 145–151

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298124/

■ Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension